M&A Deal Summary

BioMarin Pharmaceutical Acquires Prosensa

On November 24, 2014, BioMarin Pharmaceutical acquired life science company Prosensa for 680M USD

Acquisition Highlights
  • This is BioMarin Pharmaceutical’s 1st transaction in the Life Science sector.
  • This is BioMarin Pharmaceutical’s largest (disclosed) transaction.
  • This is BioMarin Pharmaceutical’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2014-11-24
Target Prosensa
Sector Life Science
Buyer(s) BioMarin Pharmaceutical
Deal Type Add-on Acquisition
Deal Value 680M USD

Target

Prosensa

Leiden, Netherlands
Prosensa is an operator of a biotechnology company that uses a unique and revolutionary licensed technology platform that makes use of so-called exon skipping for correcting mutated RNA. Prosensa company primarily targets Duchenne Muscular Dystrophy (DMD) disorder, against which it has already developed two products that are currently in clinical phase I / II. Prosensa was founded in 2002 and is based in Leiden, Netherlands.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BioMarin Pharmaceutical

San Rafael, California, United States
Category Company
Founded 1996
Sector Life Science
Employees3,401
Revenue 2.4B USD (2023)
DESCRIPTION
BioMarin's corporate headquarters in San Rafael, California.
BioMarin's corporate headquarters in San Rafael, California.

BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. BioMarin Pharmaceutical was founded in 1996 and is based in San Rafael, California.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 2 of 2
Country (Netherlands) 1 of 1
Year (2014) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-01-07 Zacharon Pharmaceuticals

San Diego, California, United States

Zacharon Pharmaceuticals, Inc. is a private biotechnology company.

Buy $10M
Mergr

Product

Company

Legal